مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

109
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

64
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics

Pages

  1-8

Abstract

 A limitation to the wider introduction of personalised dosimetry in theranostics is the relative paucity of imaging radionuclides with suitable physical and chemical properties to be paired with a long-lived therapeutic partner. As most of the betaemitting therapeutic radionuclides emit gamma radiation as well they could potentially be used as the imaging radionuclide as well as the therapeutic radionuclide. However, the downsides are that the beta radiation will deliver a significant radiation dose as part of the treatment planning procedure, and the gamma radiation branching ratio is often quite low. Gallium-67 has been in use in nuclear medicine for over 50 years. However, the tremendous interest in gallium imaging in theranostics in recent times has focused on the PET radionuclide gallium-68. In this article it is suggested that the longer-lived gallium-67, which has desirable characteristics for imaging with the gamma camera and a suitably long half-life to match biological timescales for drug uptake and turnover, has been overlooked, in particular, for treatment planning with radionuclide therapy. Gallium-67 could also allow non-PET facilities to participate in theranostic imaging prior to treatment or for monitoring response after therapy. Gallium-67 could play a niche role in the future development of personalised medicine with theranostics.

Multimedia

  • No record.
  • Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    BAILEY, DALE L., Sabanathan, Dhanusha, Campbell, Douglas H., Walsh, Bradley J., & Lengkeek, Nigel A.. (2021). RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics. ASIA OCEANIA JOURNAL OF NUCLEAR MEDICINE AND BIOLOGY, 9(1), 1-8. SID. https://sid.ir/paper/693670/en

    Vancouver: Copy

    BAILEY DALE L., Sabanathan Dhanusha, Campbell Douglas H., Walsh Bradley J., Lengkeek Nigel A.. RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics. ASIA OCEANIA JOURNAL OF NUCLEAR MEDICINE AND BIOLOGY[Internet]. 2021;9(1):1-8. Available from: https://sid.ir/paper/693670/en

    IEEE: Copy

    DALE L. BAILEY, Dhanusha Sabanathan, Douglas H. Campbell, Bradley J. Walsh, and Nigel A. Lengkeek, “RetroSPECT: Gallium-67 as a Long-Lived Imaging Agent for Theranostics,” ASIA OCEANIA JOURNAL OF NUCLEAR MEDICINE AND BIOLOGY, vol. 9, no. 1, pp. 1–8, 2021, [Online]. Available: https://sid.ir/paper/693670/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button